Scrub typhus is an acute, febrile disease caused by Orientia tsutsugamushi (21) . The disease is endemic in the Asia-Pacific region, including the People's Republic of China. For poorly understood reasons, the incidence of the disease in humans has increased sharply in China during the past 20 years. It is characterized by fever, rash, and eschar, etc. Diagnosis of scrub typhus is normally based on the clinical presentation and the patient history. However, it is difficult to differentiate scrub typhus from other acute febrile illnesses, such as murine typhus, dengue fever, and viral hemorrhagic fevers, because of the similarities in symptoms. Therefore, underdiagnosis or misdiagnosis of scrub typhus is common and may result in delayed or inappropriate treatment. Confirmatory experimental diagnosis of scrub typhus is generally based on PCR, indirect immunofluorescence assay (IFA), and immunoperoxidase test, etc. (9, 24) . However, the shortcomings of these diagnostic methods limit their usefulness. Highly sensitive PCR methods have made it possible to detect O. tsutsugamushi at the onset of illness when antibody titers are not high enough to be detected (4, 8, 18) . However, gene amplification requires special instruments and reagents generally not available in most rural hospitals. IFA is highly sensitive and specific, but it also requires an immunofluorescence microscope that may not be available in rural hospitals. Moreover, it requires cultivation of O. tsutsugamushi. The recently developed immunoperoxidase test does not need an immunofluorescence microscope, but purified O. tsutsugamushi antigen is required. However, O. tsutsugamushi is difficult to cultivate. A more practical approach to the development of newer serodiagnostic methods is to clone and express the immunodominant genes of O. tsutsugamushi in Escherichia coli. These recombinant products could then be produced and purified in adequate amounts for use as antigens in developing a convenient and inexpensive diagnostic method that would greatly reduce the cost, transport, and reproducibility problems associated with the present diagnostic tests, which require growth and purification of the orientiae.
O. tsutsugamushi is an antigenically diverse microorganism. Several antigenic variants, such as the representative strains Gilliam, Karp, and Kato, and other isolates have been reported (14) . (5, 13) . This protein is an immunodominant antigen, and its antigenic diversity depends on variation in this molecule. The 56-kDa protein is reactive with group-specific and strain-specific monoclonal antibodies, suggesting the existence of groupspecific and strain-specific epitopes in this molecule (5, 11, 12, 17) . It is known that sera from most patients with scrub typhus recognize this protein, and mice immunized with the 56-kDa protein could generate neutralizing antibodies and showed in-creased resistance to homologous O. tsutsugamushi infection (more than 160 times the 50% minimal lethal dose). These data suggest that it is a suitable diagnostic antigen and vaccine candidate (15, 16 ).
Here we report the molecular cloning and expression of the 56-kDa protein gene of O. tsutsugamushi Shanxi and the investigation of the antigenicity and immunogenicity of the recombinant protein. Finally, the diagnostic potential of this Sxh56 preparation was evaluated by enzyme-linked immunosorbent assay (ELISA) for detection of immunoglobulin G (IgG) in 563 human sera and 88 mouse sera.
MATERIALS AND METHODS
Bacterial strains and vectors. E. coli M15 was used as the host strain for the pQE30 expression vector. pQE30 was purchased from Qiagen GmbH (Hilden, Germany). Plaque-purified O. tsutsugamushi strain Shanxi was isolated from a patient in Shanxi province, People's Republic of China. O. tsutsugamushi Gilliam, O. tsutsugamushi Karp, and O. tsutsugamushi Kato were kindly supplied by I. S. Kim of the Medical College, Seoul National University.
Media and growth conditions. Luria-Bertani medium was used for routine maintenance of bacterial strains and for transformation experiments. For all strains harboring the recombinant plasmid, ampicillin (50 g/ml) was added to the culture medium. Broth cultures were grown at 37°C with vigorous shaking (200 rpm) until the mid-logarithmic phase was attained. When noted, isopropyl-␤-D-thiogalactopyranoside (IPTG) (Sigma) was added to the culture of strain M15 harboring plasmids to induce expression of the gene of interest. Nucleic acid extraction and PCR amplification. Orientiae were inoculated into chicken embryos, and the embryos were incubated at 35°C. The orientiae were harvested at 7 to 10 days postinfection, and genomic DNA was phenol-chloroform extracted as described previously (6) . A PCR kit was purchased from Gibco (Los Angeles, Calif.). Primers P1, P2, P3, and P4 were synthesized by Shanghai Sangon Company according to the published sxh56 gene sequence (GenBank accession number AF050669) (1), as follows: P1 (56F, positions 8 to 37), 5Ј-AAA TTA TGT TAA TTG CTA GTG CAA TGT CTG-3Ј; P2 (56R, positions 1522 to 1548), 5Ј-CTA GAA GTT ATA GCG TAC ACC TGC ACT TGC-3Ј; P3 (56F, positions 67 to 88), 5Ј CGC GGATCC ATA GAA TTG GGG GAT GAA GGA G; and P4 (56R, positions 1532 to 1548), 5Ј CCC AAGCTT CTA GAA GTT ATA GCG TAC AC 3Ј. Added BamHI and HindIII restriction sites are underlined. The coding sequence was amplified by nested PCR from DNA isolated from O. tsutsugamushi strain Shanxi. The 56-kDa gene was amplified in a mixture of 200 M (each) deoxynucleoside triphosphate, 0.3 M (each) primer, and 0.6 U of Taq polymerase (Gibco) in10 mM Tris-HCl buffer (pH 8.3) supplemented with 2.0 mM MgCl 2 and 50 mM KCl. The first amplification of the nested PCR was carried out with primers P1 and P2, and the second step used primers P3 and P4. The two PCRs were started with 6 min at 95°C, which was followed by 30 cycles consisting of 45 s at 94°C, 30 s at 55°C, and 90 s at 72°C. A final step of 7 min at 72°C was added to the last cycle. The products of the nested PCR were analyzed on a 1% agarose gel, and the size of the sxh56 gene was determined with the DNA/EcoT14I standard molecular weight marker (Sino-America Biotech Company, Luoyang, China).
Construction and identification of recombinant expression plasmid. All restriction enzymes were purchased from TaKaRa biotechnology Co., Ltd (Dalian, China). pQE30 and pure PCR products (1.48 kb) were digested with BamHI and HindIII and then ligated overnight at 16°C. E. coli M15 was transformed with the ligation mixture. The recombinant plasmid was constructed as described in Fig.  1 . E. coli M15 harboring the recombinant plasmid was screened with penicillin. The recombinant plasmid was also identified by digestion with BamHI and HindIII after repeated PCR, and sequences were further analyzed.
Expression and identification of the 56-kDa protein. E. coli M15 harboring the recombinant plasmid was propagated in LB (AϩK) (50 mg of ampicillin, 50 mg of kanamycin, 10 g of Bacto tryptone, 5 g of Bacto yeast extract, and 10 g of NaCl per liter of distilled water [pH 7.0]) at 37°C with shaking. When E. coli M15 transformed with the recombinant plasmid grew to logarithmic phase, the optimum concentration of IPTG was added to induce expression of the sxh56 gene. The expression of the recombinant Sxh56 was identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot assay.
SDS-PAGE and immunoblot analysis. SDS-PAGE analysis was performed with the DYY-5 protein electrophoresis system (12 by 8 by 0.75 cm; Beijing Kesheng). The stacking and separation gels contained 5 and 10% acrylamide, respectively. Electrophoresis was carried out at constant voltage of 160 V for 180 min. The gels were either stained with Coomassie blue R or electroblotted onto nitrocellulose membranes. The molecular masses of proteins were determined with a middle-molecular-mass marker (97, 66, 45, 30, 20.1, and 14.4 kDa). SDS-PAGE and immunoblot analysis were carried out as described by Laemmli (10) and Towbin et al. (22) , respectively.
Purification of the 56-kDa protein. One hundred milliliters of E. coli expressing recombinant Sxh56 induced by IPTG was centrifuged for10 min at 8,000 rpm in a Beckman Allegra 21R centrifuge (F0630 rotor), and the pellets were resuspended in 10 ml of 10 mM Tris-Cl (pH 7.0) containing 1 mM EDTA (buffer A). Disruptions of cells were performed with an Ultrasonic Processor (Kesheng Instrument Corporation, Ningbo, China) at 250 W for 60 min (30 s of sonication and a 30-s pause each time with cooling on ice). The disrupted cell extracts were centrifuged at 8,000 rpm for 30 min. The pellets were vortexed to a homogeneous suspension with buffer A (10 mM Tris-Cl [pH 7.0], 1 mM EDTA) containing 1% (vol/vol) Triton X-100 and shaken at room temperature for an additional 20 min. The suspension was centrifuged for 15 min at 7,000 rpm. The pellets were suspended in buffer A containing 2 M urea, and then the suspension was treated as described above. Finally, the pellets were dissolved in 10 ml of 10 mM Tris-Cl (pH 7.0) containing 100 mM NaH 2 PO 4 and 8 M urea (buffer B) and applied to a Ni-nitrilotriacetic acid (Ni-NTA) affinity chromatography column (Qiagen GmbH). The proteins were washed with 10 mM Tris-Cl (pH 6.3) containing 100 mM NaH 2 PO 4 and 8 M urea (buffer C) and eluted with 10 mM Tris-Cl (pH 4.5) containing 100 mM NaH 2 PO 4 and 8 M urea (buffer D) (Fig. 2) . The purification was done as described in the instructions to the Ni-NTA affinity chromatography purification kit (Qiagen GmbH).
Immunization with recombinant Sxh56 protein. Purified recombinant Sxh56 (200 g/ml) or phosphate-buffered saline was mixed with an equal volume of paraffin oil, and BALB/c mice and rabbits were immunized according to standard protocols (7). The animal experiments reported here were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals (23) .
T-cell proliferation assay by a colorimetric method. Eight days after the first booster, four mice in each group were killed and spleens were ground into single-cell suspensions in RPMI 1640 medium (Gibco, Tulsa, Okla.) supplemented with 10% fetal bovine serum for T-cell proliferation assay. They were seeded in triplicate in flat-bottom 96-well microtiter plates (Costar) at 10 6 cells per well in 100 l of culture medium with purified recombinant Sxh56 at either 10, 3, 1, or 0.3 g/ml. The plates were incubated for 3 days with 5% CO 2 at 37°C. Ten microliters of a solution of the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was then added to each culture well, and the plates were incubated for 4 h at 37°C. One hundred microliters of lysis buffer containing 10% Triton-50% isopropyl alcohol-0.01 M hydrochloric acid was then added to each well, and the plates were incubated overnight. The optical density at 570 nm (OD 570 ) and the OD 630 were measured (19) .
Sera. Mouse polyclonal sera against O. tsutsugamushi Sxh951 were prepared in our laboratory (IFA dilution, 1:5,120). Mouse sera against O. tsutsugamushi Gilliam, O. tsutsugamushi Karp, and O. tsutsugamushi Kato (IFA dilution, 1:5,120, 1:5,120, and 1:2,560, respectively) were supplied by A. Tamura. Mouse polyclonal sera against inclusion of recombinant Sxh56 proteins were prepared in our laboratory (IFA dilution, 1:10,240). Control sera were collected from healthy BALB/c mice. Sera from BALB/c mice infected with O. tsutsugamushi Gilliam were collected after 10 to 15 days. All human sera were collected from 1998 to 2001 in China. All individuals identified as positive cases were positive by IFA.
IFA. The IFA to detect antibodies in human and mouse sera was performed by using O. tsutsugamushi strain Gilliam propagated in the yolk sacs of embryonated chicken eggs according to established protocols (2, 9, 20, 25) .
ELISA. MaxiSorp plates (96 well; Nalge Nunc International, Roskilde, Denmark) were coated overnight at 4°C with antigens diluted in PBS, blocked with 3% bovine serum albumin for 1 h, and rinsed twice with PBS for 3 min each time. Mouse sera diluted from 1:20 to 1:1,280 with PBS were added to the ELISA plates. The plates were incubated for 1 h at room temperature and washed four times with 0.1% Triton X-100 in PBS. Peroxidase-conjugated goat anti-mouse IgG (Fc specific) (Sihuan Sci-Technics Company, Beijin, China) diluted 1:2,000 was added and incubated for 1 h at 37°C. The plates were washed five times with 0.1% Triton X-100 in PBS before the addition of tetramethyl-benzidine (TMB) substrate (Sihuan Sci-Technics Company), and then the reactions were stopped FIG. 5-Continued.
VOL. 71, 2003
O. TSUTSUGAMUSHI 56-kDa OUTER MEMBRANE PROTEIN ANTIGENby adding 3 M NaOH and the OD 450 s were measured. All reagents were used in a standard volume of 100 l. A positive control, a negative control, and a blank control were always included on each plate (3). For the detection of human antibodies, all procedures were the same as for the detection of mouse antibodies except that peroxidase-conjugated goat anti-human IgG (Sino-America BioTechnology Corporation) diluted 1:500 was used. Human sera were diluted 1:80 with PBS.
RESULTS
Molecular cloning of sxh56. The sxh56 gene size was determined after amplification by nested PCR. A PCR product was obtained, and the sxh56 gene size was about 1.5 kb (Fig. 3) . The results of the PCR and the restriction fragment length polymorphism reaction showed that the O. tsutsugamushi strain Sxh951 56-kDa protein gene had been cloned into the expression plasmid pQE30 (Fig. 4) . The sequence of the inserted gene was 99% homologous with the sequence reported previously (Fig. 5) 
(1).
Expression and purification of the recombinant 56-kDa protein. In order to optimize conditions for the expression of Sxh56, E. coli M15 transformed with pQE30/sxh56 was propagated at 37°C in medium containing 50 mg of ampicillin and kanamycin per liter to an OD 550 of 0.6 to 0.7, induced with 1.0 or 2.0 mM IPTG, and grown further for 2, 3, 4, or 16 h. Although the expression level of Sxh56 increased with the time of incubation, no significant differences were observed with different levels of IPTG. Recombinant Sxh56 protein was verified to react to polyclonal antiserum to O. tsutsugamushi Sxh951. In the pQE30 expression system, highly expressed recombinant proteins were inclusion bodies, as was observed in SDS-PAGE (Fig. 6 and 7) . The inclusion bodies of recombinant Sxh56 were subjected to Ni-NTA affinity chromatography for purification. The elution fractions detected by SDS-PAGE and immunoblot assay contained only recombinant Sxh56 (Fig.  8 and 9 ). Approximately 20 mg of recombinant Sxh56 could be purified from a 1-liter culture.
Immunogenicity of recombinant Sxh56 protein. In order to evaluate the ability of recombinant Sxh56 to stimulate rabbit and mouse immune responses, 8 days after the first booster, sera from mice and rabbits were collected. Sera were also collected about every 10 days for detection of IgG antibody to O. tsutsugamushi Gilliam (Table 1) . For each panel, four mice were killed, and spleen cell suspensions were prepared for detection of specific T cells (Table 2) .
Cross-reactivity of recombinant Sxh56 protein. to O. tsutsugamushi Sxh951 and O. tsutsugamushi Gilliam were positive by the immunoblot assay and ELISA with the recombinant Sxh56 (Fig. 10) . Additionally, antiserum to O. tsutsugamushi Sxh951 was incubated with recombinant 56-kDa proteins of O. tsutsugamushi Gilliam, O. tsutsugamushi Karp, and O. tsutsugamushi Kato. Only the recombinant 56-kDa protein of O. tsutsugamushi Gilliam was positive by the immunoblot assay (Fig. 11) .
Sensitivity and specificity of ELISA with recombinant Sxh56. Fifty-five normal sera from healthy BALB/c mice were collected. Thirty sera from mice infected with O. tsutsugamushi Gilliam were positive for the presence of IgG antibody against O. tsutsugamushi Gilliam in the IFA. Twenty-nine of the 30 sera from mice infected with O. tsutsugamushi Gilliam were positive in the ELISA. All of 55 normal sera were negative. Compared with the clinical presentation, the sensitivity and specificity of the ELISA with recombinant Sxh56 were 96.67 and 100%, respectively (Table 3) .
Comparison of ELISA and IFA with human sera. The results of ELISA with recombinant Sxh56 and 563 human sera from China were compared with the IgG titers determined by an IFA method with the Gilliam prototype of Orientia at a 1:80 serum dilution (9, 20) . The specificity and sensitivity of the ELISA with recombinant Sxh56 were 96.36 and 88.08%, respectively (Table 4) .
DISCUSSION
Scrub typhus, which is transmitted by trombiculid mites, occurs mainly in rural areas of the Asia-Pacific area. The diagnosis of scrub typhus is generally based on the clinical presentation and the patient history. However, an increasing number of cases having no typical symptoms have been reported, and some drug-resistant strains were isolated recently. It is very difficult to differentiate scrub typhus from other acute febrile illnesses, such as murine typhus, dengue fever, and viral hemorrhagic fevers, etc., because of the similarities in signs and symptoms. Underdiagnosis or misdiagnosis of scrub typhus is common and may result in delayed or inappropriate treatment. 
